Home Molecular Dx Cardiovascular Testing

Cardiovascular Testing

Latest
Unrecognizable businessman having chest pain and heart attack
Cardiovascular Testing

Microbes on Tongue Could Aid Heart Failure Diagnosis

Unrecognizable businessman having chest pain and heart attack
Cardiovascular Testing

PRS Finds Patients at Risk for Heart Attack Missed by Standard...

Unrecognizable businessman having chest pain and heart attack
Cardiovascular Testing

PRS Only Marginally Better than Established Methods of Predicting Heart Disease

Cardiovascular Testing

ACMG Launches Evidence-Based Guidelines for Genetic, Genomic Testing

Source: © vishnukumar/Fotolia.com
Cardiovascular Testing

Epigenetic Changes Implicated in Congestive Heart Failure

Agena Bioscience will co-promote its MassARRAY® DX clinical diagnostics technology with HeartGenetics' genetic testing software (pictured) and other CE-IVD marked products. [HeartGenetics]
Cardiovascular Testing

Agena to Co-Promote Clinical Dx Technology With HeartGenetics’ Software, Assays

Source: hh580/Getty Images
Cardiovascular Testing

Regeneron, Geisinger Publish Details of Precision Medicine Collaboration

Source: iStock / IS_ImageSource / D3Damon
Cardiovascular Testing

Heart-Stopping Incidental Findings Are Often Non-Starters

NGS technology has enabled researchers to epidemiologically analyze DNA sequences by quickly deciphering mass quantities of genetic information in a short amount of time. [Heart illustration: iStock/SvetaP DNA double helix: iStock/Kagenmi]
Cardiovascular Testing

At the Heart of the Matter: The Genomics Underlying Cardiovascular Disease

Load more

New Products

View More
Load more
Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up